Best Life Sciences Companies in Overijssel, Netherlands
The 43 best Life Sciences companies in Overijssel, Netherlands in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Hy2Care.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Overijssel
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ANT Neuro Digital neurodiagnostic solution for providers | — | — | 68 | — | BackdropOdooCart Functionality+18 | Top 5M | — | 1 partnership |
| 2 | BestMedical Systems for diagnostics and treatment in Urology & Urogynecology | — | — | — | Ger Dijkman Founder & Director | — | — | — | — |
| 3 | DentalColors A range of dental products | — | — | — | William Ankone Founder | — | — | 6 patents Dental indicator liquid containers for practice use | — |
| 4 | DermalDose Intradermal drug delivery system | — | — | — | Nol Brouwers Founder & Director | — | — | — | — |
| 5 | Duplaco Microalgae producer for dietary supplements, food ingredients, and feed markets | — | — | 9 | — | — | — | — | — |
| 6 | Dynamic Provider of ultrasound equipment and training services | — | — | — | Petra Massink Owner | — | — | — | — |
| 7 | eMaldi Instruments for next generation MALDI-MS | — | — | — | Frieder Mugele Co-Founder | — | — | — | — |
| 8 | Finapres Non-invasive hemodynamic monitoring devices | — | — | 11 | — | Node.jsAmazon Web ServicesGSAP+15 | Top 50M | — | — |
Top 12 Life Sciences companies in Overijssel
#1
Series B · Enschede, Overijssel · founded 2014 · 12 employees$10.5Mraised▾
Developer of a hydrogel implant for cartilage defect repair. It facilitates the natural repair of cartilage defects in joints. The hydrogel is biocompatible, mimicking natural joint tissue polymers to protect the injured area and encourage healing. It provides a scaffold for the patient cells to regenerate cartilage to alleviate pain and restore joint function. It addresses the significant unmet need for effective cartilage repair, preventing the progression to osteoarthritis.
- May 2025Series B$5M
- Jun 2022Series B$6.3M
- May 2019Series A$4.1M
- Jun 2016Grant (prize money)$55.9K
#2
Funding Raised · Enschede, Overijssel · founded 1999 · 13 employees$6.1Mraised▾
Micronit started with initial focus on miniaturization of devices using micro technology. It then focused on microfluidics for life sciences applications and has grown into a complete lab-on-chip product development partner. It also provides micro machining services through its MEMS division. Micronit has its own clean room manufacturing facilities, which are set up for wafer scale and batch processing of glass and silicon and are thus ideally suited for wafer-based MEMS applications.
- Jan 2024Grant (prize money)$230.3K
- Sep 2021Grant (prize money)$534.5K
- Feb 2021Grant (prize money)$212.3K
- Jan 2021Grant (prize money)$325.7K
#3
Funding Raised · Almelo, Overijssel · founded 2017 · 1771 employees$7.5Mraised▾
R&D company focused on manufacturing of medical instruments for multiple industries
- Sep 2021Grant (prize money)$107.3K
- Jul 2021Grant (prize money)$140.8K
- May 2020Grant (prize money)$937.4K
- Oct 2018Grant (prize money)$18.2K
#4
Series A · Enschede, Overijssel · founded 2018 · 32 employees$5.1Mraised▾
Provider of in-air microfluidics technology for research. The company's technology helps with microparticle production needs. The company has produced single and double emulsions, along with Janus hydrogel beads and cell capsules with their technology.
- Oct 2022Series A$3.9M
- Dec 2018Seed$1.1M
#5
Seed · Enschede, Overijssel · founded 2018 · 11 employees$2Mraised▾
Developer of stem-cell-derived organoid models for cardiac drug discovery. The company develops 3D cardiac models including, 3D cardiac strips, heart-on-a-chip, and the highly innovative mini heart, to support drug discovery programs. The company has two drug discovery programs for heart failure and myocardial infarction.
- Nov 2022Grant (prize money)$109.1K
- Jan 2022Seed$2M
#6
Funding Raised · Oldenzaal, Overijssel · founded 2000 · 45 employees$1.5Mraised▾
TMS International produces high-precision multi-channel amplifiers, data acquisition, and communication solutions, first and foremost for (electro-) physiological applications. Their technology has applications in measurement of Bioelectric signals in electrically active tissue like the heart, the muscles or the brain. For example, the technology is used to produce EEG, ECG and EMG machines to measure brain waves, heartbeat, and muscle excitement. The company offers Saga, Refa, Mobita, Mobi, and Porti which are multi-channel electrophysiological measurement devices
- Oct 2022Grant (prize money)$343.1K
- Jan 2018Grant (prize money)$306.7K
- Jun 2017Grant (prize money)$455.5K
- Mar 2016Grant (prize money)$364.8K
#7
Series A · Enschede, Overijssel · founded 2008 · 21 employees$5.7Mraised▾
Manufacturer of silicon microneedle for intradermal injections. The company offered its product Bella-mu used for drug delivery in vaccination and aesthetics by using the Mantoux technique. The microneedle injection technology is used to targets dendritic cells of the immune system to reduced anxiety & pain.
- Sep 2020Series A$5.7M
#8
Series A · Enschede, Overijssel · founded 2004$876.9Kraised▾
Optisense develops biosensors for real-time monitoring of contaminants and biochemical substances. Using the combination of an integrated optic chip, a biochemical transduction layer, micro-fluidics and electronics, the company has developed ‘Lab-on-Chip’ sensor technology that responsds to the high-end laboratory sensitivity (lower parts per billion range). The Optisense sensor technology can be used in a number of sector such as Water, Agriculture, Medical Diagnostics and others. Optisense's Water related activities are managed by its subsidiary Optiqua.
- May 2017Grant (prize money)$876.9K
- 2009Series A—
#9
Funding Raised · Enschede, Overijssel · founded 2010 · 7 employees$858.9Kraised▾
PA Imaging provides screening and diagnostic mammograms. The company uses photo-acoustic technology to provide a non-invasive solution for the diagnosis of breast tumors. The company has a real-time tomography software with its device that translates information into a comprehensive 3D image of the breast.
- Jan 2017Grant (prize money)$858.9K
#10
Funding Raised · Enschede, Overijssel · founded 2016$112.3Kraised▾
Developer of therapeutics for the treatment of cancer. The company has designed small peptide inhibitors to block integrin alpha5beta1 receptor which play a crucial role in the progression of fibrotic diseases including sclerosis, idiopathic pulmonary fibrosis, and pancreatic tumor stroma, etc.
- May 2019Grant (prize money)$55.7K
- Dec 2018Grant (prize money)$56.6K
#11
Seed · Goor, Overijssel · founded 2003 · 65 employees$10Kraised▾
Inreda Diabetic is a developer of a bi-hormonal artificial pancreas. It autonomously regulates the glucose levels without using the carbohydrate values, calculating and injecting insulin, etc. It senses the amount of glucose in blood and its trend. It can infuse either insulin to lower the blood glucose level or infuse glucagon to rise it.
- Jul 2022Seed—
- Sep 2012Grant (prize money)$10K
#12
Funding Raised · Enschede, Overijssel · founded 2020 · 5 employees$56.5Kraised▾
Developer of ultrasound contrast agents for the diagnosis of multiple diseases. The company's proprietary technology has developed Harmono-T intravenous ultrasound contrast agent filled with lipid-coated gas microbubbles. It enhances ultrasound images that allow clinicians to obtain functional information related to the perfusion of the patient’s organs as well as the peripheral vasculature.
- Feb 2015Grant (prize money)$56.5K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the Netherlands
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 513 Netherlands-affiliated papers.
- Wageningen University & Research116
- Utrecht University59
- Leiden University Medical Center43
- Netherlands Institute of Ecology35
- Erasmus MC30
- Messenger RNA1→6
- Gene3→7
- DNA damage1→5
- Immune system1→5
- DNA repair1→4
- Gene1→5
- Biological pest control1→4
- Population1→4
- Production (economics)1→5
- Public health1→4
- Food security2→4
- Food safety2→4
Where biotechnology is researched across Netherlands
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.